Pharma Journalist - Page 802 of 957 -

Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps

CSL, Alentis Partner on $1.55B Kidney and Liver Drug

Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B

Biohaven enrolls first patient in Phase 3 Clinical Trial to assess Rimegepant Zydis ODT to treat Migraine

Apexigen and Pediatric Brain Tumor Consortium collaborate to evaluate APX005M in Brain tumor children

Citius Pharmaceuticals conveys progress in Hemorroid Treatment Program

Introducing the 2nd Annual HPAPI Conference this May 2018

Discover Novel Based Vial Based Technology, Presented by Roche this May

FDA authorization extended to 23andMe for Direct-to Consumer Genetic Test on Cancer Risk

Theratechnologies states FDA approval of innovative therapy, Trogarzo Injection

FDA sanctions Trogarzo as HIV treatment for untreated patients